The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs raises treace medical concepts price target to ten dollars maintains neutral rating
UBS has raised the price target for Treace Medical Concepts, Inc. to $10 from $7.90 while maintaining a neutral rating. The company specializes in medical technology for bunion and midfoot deformities, offering patented systems like the Lapiplasty 3D Bunion Correction System and the Adductoplasty Midfoot Correction System, which are designed to improve surgical outcomes and patient recovery. Their products are sold to healthcare providers across the United States.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.